Boost Clinical Lab Efficiency with the ThunderBolt EIA+CLIA Automation Platform
16 Aug 2012

Gold Standard Diagnostics (GSD) have announced the addition of fully-automated Chemiluminescence Immunoassay (CLIA) processing capability to the powerful ThunderBolt® Automation Platform. With the ability to simultaneously automate CLIA alongside EIA, laboratories of any size can now achieve even more dramatic increases in throughput, flexibility and cost savings.

Through a host of patent-pending features, the ThunderBolt® delivers exceptional power and flexibility in a small size. The dual function analyzer provides complete, walk-away automation of 192 patient samples in only a 2’ by 2’ space. Completely open architecture allows any EIA or CLIA protocol to be programmed, and up to eight different protocols to run in a single batch. Intuitive and robust software further enriches the ThunderBolt®, making it the total laboratory automation solution.

Gold Standard Diagnostics also boasts a suite of over 200 “ThunderBolt-Ready” assays from more than 20 different manufacturers. Each validated protocol in the large library deploys seamlessly on the ThunderBolt® to realize maximum laboratory benefit as quickly as possible. GSD also supports the entire solution of reagents and instrumentation to guarantee smooth operation and maximum uptime.

Request Info


Company website

Gold Standard Diagnostics
profile photo

Sonia Nicholas
Clinical Diagnostics Editor  




Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!